Variable | GPCPa | EPGb | MDc |
---|---|---|---|
n = 35 | n = 21 | n = 20 | |
Median; mean (SD) | Median; mean (SD) | Median; mean (SD)) | |
Age in years | 86.0; 85.0 (7.5) | 87.0; 84.8 (7.2) | 87.5; 88.0 (5.6) |
Baseline QoLd (EQ-5D score) | 0.33; 0.38 (0.33) | 0.45; 0.46 (0.26) | 0.38; 0.41 (0.33) |
Baseline functional status (Barthel Index) | 57.0; 55.5 (23.3) | 61.0; 59.8 (19.2) | 60.5; 58.4 (20.9) |
Baseline cognitive function (SMMSEe score)* | 25.0; 23.3 (5.7) | 19.5; 19.2 (5.8) | 23.5; 23.4 (4.3) |
Baseline depressive symptoms (GDS-15f score) | 6.0; 5.8 (2.7) | 5.0; 5.6 (2.9) | 4.5; 6.0 (3.6) |
Body mass index (BMI)g | 22.2; 23.6 (6.5) | 24.0; 24.9 (5.3) | 22.9; 23.9 (5.0) |
Gender [n,(%) male] | 15 (43) | 12 (57) | 5 (25) |
n (%) who had a QoLh gain over 12 months | 13 (41) | 7 (41) | 8 (44) |
n (%) who had died at the end of 12 months | 10 (29) | 6 (29) | 2 (10) |
Place of death [n (%) in each column] | |||
Hospital | 6 (60) | 3 (50) | 1 (50) |
Residential Care/Respite | 4 (40) | 3 (50) | 1 (50) |
Home/Independent living unit | 0 | 0 | 0 |
When AD was completedi | |||
Before admission to TCj | 0 | 17 (81) | 5 (25) |
During admission to TCj | 35 (100) | 2 (10) | 15 (70) |
Trial Arm | |||
Intervention* | 30 (86) | 14 (67) | 9 (45) |
Usual care* | 5 (14) | 7 (33) | 11 (55) |